Clinical trial
Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
NCT00102830 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00102830 |
|---|---|
| Title | Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors |
| Official title | A Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of AMG 386 in Adult Patients With Advanced Solid Tumors |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tumors |
| Intervention type | Drug |
| Interventions | AMG 386 |
| First posted | Feb 4, 2005 |
| Last update posted | Aug 20, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: